On November 17th, 2023, the "China Pharmaceutical Industry Development Conference 2023" jointly organized by the Ministry of Industry and Information Technology, the People's Government of Beijing Municipality, National Health Commission, State-owned Assets Supervision and Administration Commission of the State Council, National Administration of Traditional Chinese Medicine and National Medical Products Administration opened in Beijing.

The 40th China Pharmaceutical Industry Information Annual Conference 2023 was held on November 18th, released the list of "Top 100 Pharmaceutical Industries in China in 2022" and "Enterprises with the Most Investment Value in China Pharmaceutical Industry".

In this selection, Tianjin Pharmaceutical Holdings Co., Ltd. ranked 36th in the list with its excellent R&D and production capabilities and steady marketing ability. This is not only the affirmation of the strength of Tianjin Pharmaceutical Holdings Co., Ltd., but also the recognition of its outstanding contribution in the pharmaceutical industry.

At the same time, Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, a subsidiary of Tianjin Pharmaceutical Holdings Co., Ltd, was honored with the title of "China's Best Enterprise in Pharmaceutical Industry in 2022", demonstrating the strength of a leading enterprise in innovative Chinese medicine.

As a market-driven and technology-enabled health industry leader, Tianjin Pharmaceutical Holdings Co., Ltd. has always adhered to the core value concept of " Love, Integrity, Power" and closely focused on people's health needs while constantly improving its product quality and service level.

Working hard and striving forward with honors. In the future development, Tianjin Pharmaceutical Holdings Co., Ltd. will keep on innovating and reforming, constantly improve its R&D and production strength and market competitiveness, and make greater contributions to safeguarding people's health and promoting the development of pharmaceutical industry.